Revenue market share of probiotics and gastrointestinal drugs sold in Spain 2017-2018

This statistic displays the market share of probiotics and gastrointestinal drugs sold in Spain between October 2017 and September 2018, based on revenue and by pharmaceutical company. Over the period of time under consideration, Italfarmaco was the leading provider of these pharmaceutical products in Spain, accounting for almost 18 percent of total units sold within this segment.

Revenue market share of probiotics and gastrointestinal drugs sold in Spain between October 2017 and September 2018, by pharmaceutical company

Revenue market share
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

December 2018

Region

Spain

Survey time period

October 2017 to September 2018

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Influenza in the U.S."

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.